Anzeige
Mehr »
Sonntag, 30.08.2026 - Börsentäglich über 12.000 News
Breaking News: NurExone läutet die nächste Runde ein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
734 Leser
Artikel bewerten:
(2)

Nitches, inc: InTheZoneLabs Nootropic Solutions Prove Transformative for Veterans and First Responders

Company Announces GovX Integration, 30% Discount, and Ongoing Support for Service Communities

MIAMI, FL / ACCESS Newswire / January 22, 2025 / Nitches Inc. (OTC PINK:NICH) - InTheZoneLabs® today announced its growing impact within the veteran and first-responder communities, highlighting testimonials from service members who have experienced improved mental clarity, focus, and restorative sleep through the company's nootropic supplements. The brand, which features scientifically backed ingredients like L-theanine, lion's mane mushroom, alpha-GPC, and phosphatidylserine, is dedicated to providing an alternative that may help reduce reliance on certain prescription drugs.

Empowering Service Members, One Capsule at a Time
Sgt. Erik Wacker (Bronze Star, 2017-Present) offered a powerful testimonial reflecting on his 22 years of active-duty service in the Army, including seven combat deployments to Afghanistan and Iraq:

"Once I got out, everything was in slow motion and I was getting a lot of brain fog. I was then given the opportunity to get InTheZone Focused Extreme. InTheZone has really worked for me and my brain fog is gone-I feel like I am back to myself again. I am focused on my current work in law enforcement and now I am zeroed in again! Thank you InTheZone, you have a lifelong customer!"

GovX Partnership & Discount
Acknowledging the exceptional dedication of veterans, first responders, and teachers, InTheZoneLabs® has integrated with GovX to provide a 30% discount to all members who visit inthezonelabs.com and verify their status. GovX-known for its broad reach across military, law enforcement, firefighter, EMS, and related communities-serves millions of verified members. InTheZoneLabs® invites all eligible individuals to take advantage of this exclusive offer on its homepage, while also making products available via Amazon and the TikTok Shop.

Better Brain Health, Rest, and Performance
Backed by a carefully curated formula, InTheZoneLabs® products are designed to help individuals stay sharp at work, tackle demanding schedules, and unwind more effectively at the end of the day. The brand's commitment to holistic well-being aligns with mounting evidence that natural nootropic ingredients can enhance cognitive performance without the downsides often associated with prescription stimulants.

About InTheZoneLabs®
Dedicated to helping everyday heroes and high-achievers alike optimize mental clarity, focus, and resilience, InTheZoneLabs® provides an array of supplements formulated with proven natural ingredients. By blending science and innovation, the company aims to offer unparalleled support for those who serve our nation and communities.

FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. InTheZoneLabs® products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Forward-Looking Statements:
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact Information
John Morgan
Ceo
info@nitchescorp.com

SOURCE: Nitches, inc



© 2025 ACCESS Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.